A majority of patients with tuberculosis (TB) in the Big Seven (India, Indonesia, Bangladesh, Myanmar, Nigeria, Pakistan, The Philippines) are diagnosed and treated in the private sector. Yet, most private providers do not use the most recent WHO-endorsed diagnostic tests, including microbiological tests such as liquid cultures, line probe assays and Xpert MTB/RIF. Several challenges can be identified including a combination of factors such as lack of awareness, misaligned incentives and high prices that are unaffordable for patients.

In this webinar we hear from diverse challenges and approaches in The Philippines, India and Nigeria to transform the markets (pricing and volume) to improve the uptake of diagnostic tests in private laboratories.

----------
The overall outline of the webinar is as follows:

Panel Presentations:

Challenges and solutions in engaging private laboratories in Nigeria ( 10min) – Taofeekat Ali, IHV
India’s IPAQT lessons on engaging private laboratories (10min) – Arnab Pal, CHAI India
Collaborative efforts to increase TB diagnostics in the Philippines (10min) – Lalaine Mortera, FHI360
Comments (2-5min) – Dene Grindal, Cepheid

Q & A moderated by Madhu Pai

-------------
Check out other TBPPM Webinars: [ Ссылка ]

Be a part of the TBPPM Learning Network: [ Ссылка ]

Follow us on Twitter: [ Ссылка ]

свернуть